VisAble.IO
Radiological Image Processing Software For Ablation Therapy Planning And Evaluation. 510(k) K240773, from Techsomed (Rehovot, IL). Product code QTZ, class 2.
As of Nov 20, 2026, K240773 is an FDA 510(k) held by Techsomed, substantially equivalent on Apr 15, 2024 after 25 days, with no recalls tied to it in FDA's recall database.
- Review time: 25 days
- Recalls: 0
- Cited as a predicate by: 1 device
VisAble.IO is a Computed Tomography (CT) and Magnetic Resonance (MR) image processing software package available for use with liver ablation procedures. VisAble.IO is controlled by the user via a user interface. VisAble.IO imports images from CT and MR scanners and facility PACS systems for display and processing during liver ablation procedures.
- VisAble.IOK223639 · Techsomed · Aug 28, 2023
- Electric breast pump (model: M5)K223693 · Shenzhen Lutejiacheng Technology Co., Ltd. · Mar 9, 2023
- BioTraceIO Vision (V1.7)K251931 · Techsomed Medical Technologies · Sep 8, 2025
- myAblation Guide (VC10A)K253264 · Siemens Healthcare GmbH · Jun 16, 2026
- HistoSonics® Planning ToolK252947 · HistoSonics, Inc. · May 29, 2026
- BioTraceIO Vision (V1.7)K251931 · Techsomed Medical Technologies · Sep 8, 2025
- myAblation Guide (VB80A)K240796 · Siemens Healthcare GmbH · Aug 6, 2024
- Artemis, Artemis TPO, Artemis MXK222222 · Eigen · Oct 12, 2023
- Ablation-fitK222938 · R.A.W. S.R.L · Sep 12, 2023
- VisAble.IOK223639 · Techsomed · Aug 28, 2023
- MIM-AblationK220256 · Mim Software, Inc. · Oct 7, 2022
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Mar 21, 2024
- Review panel
- Radiology
- Regulation
- 21 CFR 892.2050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files